sábado, 16 de septiembre de 2023

FDA Issues Warning Letters to Three Infant Formula Manufacturers

https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-three-infant-formula-manufacturers?utm_medium=email&utm_source=govdelivery FDA Issues Warning Letters to Three Infant Formula Manufacturers Actions are Part of Enhanced Oversight; FDA Does Not Advise Discarding or Avoiding Purchase of Any Particular Infant Formula The U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.

No hay comentarios:

Publicar un comentario